N-cadherin-mediated adhesion and aberrant catenin expression in anaplastic thyroid-carcinoma cell lines

International Journal of Cancer

Volumn 83, Issue 5, 1999, Pages 692-699

  Husmark, Johanna ^a   Heldin, Nils Erik ^b   Nilsson, Mikael ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CATENIN; CYTOKERATIN; NERVE CELL ADHESION MOLECULE;

ANAPLASTIC CARCINOMA; ARTICLE; BIOTINYLATION; CANCER CELL CULTURE; CANCER GROWTH; CELL ADHESION; CONTROLLED STUDY; DEMETHYLATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; PRIORITY JOURNAL; THYROID CARCINOMA;

ALPHA CATENIN; BETA CATENIN; CADHERINS; CARCINOMA; CELL ADHESION; CELL ADHESION MOLECULES; CYTOSKELETAL PROTEINS; DESMOPLAKINS; GAMMA CATENIN; HUMANS; NEOPLASM PROTEINS; PHOSPHOPROTEINS; THYROID NEOPLASMS; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0032706001     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991126)83:5<692::AID-IJC21>3.0.CO;2-1     Document Type: Article

References (34)

1. ABERLE, H., SCHWARTZ, H. and KEMLER, R., Cadherin-catenin complex: protein interactions and their implications for cadherin function. J. Cell Biochem., 61, 514-523 (1996).
2. BEN-ZE'EV, A. and GEIGER, B., Differential molecular interactions of β-catenin and plakoglobin in adhesion, signaling and cancer. Curr. Opin. Cell Biol., 10, 629-639 (1998).
3. BRABANT, G., HOANG-VU, C., CETIN, Y., DRALLE, H., SCHEUMANN, G., MÖLNE, J., HANSSON, G., JANSSON, S., ERICSON, L.E. and NILSSON, M., E-cadherin: a differentiation marker in thyroid malignancies. Cancer Res., 54, 4987-4993 (1993).
4. BULLIONS, L.C., NOTTERMAN, D.A., CHUNG, L.S. and LEVINE, A.J., Expression of wild-type α-catenin protein in cells with a mutant α-catenin gene restores both growth regulation and tumor-suppressor activities. Mol. cell. Biol., 17, 4501-4508 (1997).
5. BUTZ, S., STAPPERT, J., WEISSIG, H. and KEMLER, R., Plakoglobin and beta-catenin: distinct but closely related. Science, 257, 1142-1144 (1992).
6. CERRATO, A., FULCINITI, F., AVALLONE, A., BENINCASA, G., PALOMBINI, S. and GRIECO, M., Beta- and gamma-catenin expression in thyroid carcinomas. J. Pathol., 185, 267-272 (1998).
7. cas binds directly to E-cadherin but not to the adenomatous-polyposis-coli protein or α-catenin. Mol. cell. Biol., 15, 4819-4824 (1995).
8. FRIXEN, U.W., BEHRENS, J., SACHS, M., EBERLE, M., VOSS, B., WARDA, A., LÖCHNER, D. and BIRCHMEIER, W., E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol., 113, 173-185 (1991).
9. GRAFF, J.R., GREENBERG, V.E., HERMAN, J.G., WESTRA, W.H., BOGHAERT, E.R., AIN, K.B., SAJI, M., ZEIGER, M.A., ZIMMER, S.G. and BAYLIN, S.B., Distinct patterns of E-cadherin CpG methylation in papillary, follicular, Hürthle's cell and poorly differentiated human thyroid carcinoma. Cancer Res., 58, 2063-2066 (1998).
10. GRAFF, J.R., HERMAN, J.G., LAPIDUS, R.G., CHOPRA, H., XU, R., JARRARD, D.F., ISAACS, W.B., PITHA, P.M., DAVIDSON, N.E. and BAYLIN, S.B., E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res., 55, 5195-5199 (1995).
11. HAZAN, R.B., KANG, L, WHOOLEY, B.P. and BORGEN, P.I., N-cadherin promotes adhesion between invasive breast-cancer cells and the stroma. Cell Adhes. Comm., 4, 399-411 (1997).
12. HUANG, S.H., WU, J.C., LIAW, K.Y. and WANG, S.M., Distribution of the cadherin-catenin complex in normal human thyroid epithelium and a thyroid-carcinoma cell line. J. Cell Biochem., 70, 330-337 (1998).
13. ISLAM, S., CAREY, T.E., WOLF, G.T., WHEELOCK, W.J. and JOHNSON, K.R., Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J. Cell Biol., 135, 1643-1654 (1996).
14. KARLSSON, J.O., OSTWALD, K., KÅBJÖRN, C. and ANDERSSON, M., A method for protein assay in Laemmli buffer. Anal. Biochem., 219, 144-146 (1994).
15. LAMPUGNANI, M.G., CORADA, M., CAVEDA, L., BREVIARIO, F., AYALON, O., GEIGER, B. and DEJANA, E., The molecular organization of endothelial cell-to-cell junctions: differential association of plakoglobin, β-catenin, and α-catenin with vascular endothelial cadherin (VE-cadherin). J. Cell Biol., 129, 203-217 (1995).
16. MAREEL, M.M., BEHRENS, J., BIRCHMEIER, W., DE BRUYNE, G.K. and VLEMINCKX, K., Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice. Int. J. Cancer, 47, 922-928 (1991).
17. MAREEL, M.M., BRACKE, M. and VAN ROY, F., Cancer metastasis: negative regulation by an invasive-suppressor complex. Cancer Detect. Prev., 19, 451-464 (1995).
18. cas isoforms in human tumor cell lines. Cancer Res., 56, 2633-2640 (1996).
19. NAVARRO, P., LOZANO, E. and CANO, A., Expression of E-or P-cadherin is not sufficient to modify the morphology and the tumorigenic behavior of murine spindle carcinoma cells: possible involvement of plakoglobin. J. Cell Sci., 105, 923-934 (1993).
20. NILSSON, M., HUSMARK, J., NILSSON, B., TISELL, L-E. and ERICSON, L.E., Primary culture of human thyrocytes in Transwell bicameral chamber: thyrotropin promotes polarization and epithelial barrier function. Europ. J. Endocrinol., 135, 469-480 (1996).
21. 2+ removal and cytochalasin B. Europ. J. Cell Biol., 56, 308-318 (1991).
22. OVERDUIN, M., HARVEY, T.S., BAGBY, S., TONG, K.I., YAU, P., TAKEICHI, M. and IKURA, M., Solution structure of the epithelial cadherin domain responsible for selective cell adhesion. Science, 267, 386-389 (1995).
23. PANTEL, K., PASSLICK, B., VOGT, J., STOSIEK, P., ANGSTWURM, M., SEEN-HIBLER, R., HAUSSINGER, K., THETTER, O., IZBICKI, J.R. and REITHMULLER, G., Reduced expression of plakoglobin indicates an unfavourable prognosis in sub-sets of patients with non-small-cell lung cancer. J. clin. Oncol., 16, 1407-1413 (1998).
24. PARKER, H.R., LI, Z., SHEININ, H., LAUZON, G. and PASDAR, M., Plakoglobin induces desmosome formation and epidermoid phenotype in N-cadherin-expressing squamous carcinoma cells deficient in plakoglobin and E-cadherin. Cell Motil. Cytoskel., 40, 87-100 (1998).
25. cas binds classical cadherins and induces an unusual morphological phenotype in NIH3T3 fibroblasts. Exp. Cell Res., 225, 328-337 (1996).
26. ROKHLIN, O.W. and COHEN, M.B., Expression of cellular adhesion molecules on human prostate-tumor cell lines. Prostate, 26, 205-212 (1995).
27. SERINI, G., TRUSOLINO, L., SAGGIORATO, E., CREMONA, O., DEROSSI, M., ANGELI, A., ORLANDI, F. and MARCHISIO, P., Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue. J. nat. Cancer Inst., 88, 442-449 (1996).
28. SHIMOYAMA, Y., NAGAFUCHI, A., FUJITA, S., GOTOH, M., TAKEICHI, M., TSUKITA, S. and HIROHASHI, S., Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness. Cancer Res., 52, 5770-5774 (1992).
29. SIMCHA, I., GEIGER, B., YEHUDA-LEVENBERG, S., SALOMON, D. and BEN-ZE'EV, A., Suppression of tumorigenicity by plakoglobin: an augmenting effect of N-cadherin. J. Cell Biol., 133, 199-209 (1996).
30. SKOUDY, A., GOMEZ, S., FABRE, M. and GARCIA DE HERREROS, A., p120-catenin expression in human colorectal cancer. Int. J. Cancer, 68, 14-20 (1996).
31. SOARES, P., BERX, G., VAN ROY, F. and SOBRINHO-SIMOES, M., E-cadherin-gene alterations are rare events in thyroid tumors. Int. J. Cancer, 70, 32-38 (1997).
32. VOLK, T. and GEIGER. B., A-CAM: a 135-kD receptor of intercellular adherens junctions. II. Antibody-mediated modulation of junction formation. J. Cell Biol., 103, 1451-1464 (1986).
33. VON WASIELEWSKI, R., RHEIN, A., WERNER, M., SCHEUMMAN, G.F.W., DRALLE, H., PÖTTER, E., BRABANT, G. and GEORGII, A., Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome. Cancer Res., 57, 2501-2507 (1997).
34. ctn. J. Cell Biol., 141, 779-789 (1998).